Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Valiant Laboratories IPO is a book built issue of Rs 152.46 crores. The issue is entirely a fresh issue of 1.09 crore shares.
Valiant Laboratories IPO bidding started from September 27, 2023 and ended on October 3, 2023. The allotment for Valiant Laboratories IPO was finalized on Thursday, October 5, 2023. The shares got listed on BSE, NSE on October 6, 2023.
Valiant Laboratories IPO price band is set at ₹133 to ₹140 per share. The minimum lot size for an application is 105 Shares. The minimum amount of investment required by retail investors is ₹14,700. The minimum lot size investment for sNII is 14 lots (1,470 shares), amounting to ₹205,800, and for bNII, it is 69 lots (7,245 shares), amounting to ₹1,014,300.
Unistone Capital Pvt Ltd is the book running lead manager of the Valiant Laboratories IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Valiant Laboratories IPO RHP for detailed information.
| IPO Date | September 27, 2023 to October 3, 2023 |
| Listing Date | October 6, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹133 to ₹140 per share |
| Lot Size | 105 Shares |
| Total Issue Size | 10,890,000 shares (aggregating up to ₹152.46 Cr) |
| Fresh Issue | 10,890,000 shares (aggregating up to ₹152.46 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding post issue | 43,450,000 |
Valiant Laboratories IPO offers 10,890,000 shares. 2,178,030 (20.00%) to QIB, 1,633,500 (15.00%) to NII, 3,811,500 (35.00%) to RII 3,266,970 (30.00%) to Anchor investors. 36,300 RIIs will receive minimum 105 shares and 370 (sNII) and 740 (bNII) will receive minimum 1,470 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 3,266,970 (30.00%) | NA |
| QIB Shares Offered | 2,178,030 (20.00%) | NA |
| NII (HNI) Shares Offered | 1,633,500 (15.00%) | |
| bNII > ₹10L | 1,088,999 (10.00%) | 740 |
| sNII < ₹10L | 544,501 (5.00%) | 370 |
| Retail Shares Offered | 3,811,500 (35.00%) | 36,300 |
| Total Shares Offered | 10,890,000 (100%) |
Valiant Laboratories IPO raises Rs 45.74 crore from anchor investors. Valiant Laboratories IPO Anchor bid date is September 26, 2023. Valiant Laboratories IPO Anchor Investors list
| Bid Date | September 26, 2023 |
| Shares Offered | 3,266,970 |
| Anchor Portion Size (In Cr.) | 45.74 |
| Anchor lock-in period end date for 50% shares (30 Days) | November 4, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | January 3, 2024 |
Valiant Laboratories IPO opens on September 27, 2023, and closes on October 3, 2023.
| IPO Open Date | Wednesday, September 27, 2023 |
| IPO Close Date | Tuesday, October 3, 2023 |
| Basis of Allotment | Thursday, October 5, 2023 |
| Initiation of Refunds | Friday, October 6, 2023 |
| Credit of Shares to Demat | Friday, October 6, 2023 |
| Listing Date | Friday, October 6, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on October 3, 2023 |
Investors can bid for a minimum of 105 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1365 | ₹191,100 |
| S-HNI (Min) | 14 | 1,470 | ₹205,800 |
| S-HNI (Max) | 68 | 7,140 | ₹999,600 |
| B-HNI (Min) | 69 | 7,245 | ₹1,014,300 |
| Lot Size Calculator | |||
Shantilal Shivji Vora, Santosh Shantilal Vora, and Dhanvallabh Ventures LLP (DVL) are the company's promoters.
| Share Holding Pre Issue | 100.00% |
| Share Holding Post Issue | 74.94% |
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 106.31 | 181.81 | 212.76 |
| Revenue | 183.78 | 293.47 | 338.77 |
| Profit After Tax | 30.59 | 27.50 | 29.00 |
| Net Worth | 88.58 | 71.46 | 100.49 |
| Reserves and Surplus | |||
| Total Borrowing | 0.35 | 60.68 | 59.40 |
The market capitalization of Valiant Laboratories IPO is Rs 608.3 Cr.
| KPI | Values |
|---|---|
| ROE | 33.73% |
| ROCE | 22.76% |
| Debt/Equity | 0.59 |
| RoNW | 28.86% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 8.91 | |
| P/E (x) | 15.71 |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
[Dilip Davda] The company is in the business of manufacturing APIs and bulk drugs with a prime focus on widely used paracetamol. However, the company has posted declining trends for its PAT and RoCE margins for the reported periods. Based on FY23 earnings, the issue appears fully priced. Investors may park funds for medium to long-term rewards. Read detail review...
The Valiant Laboratories IPO is subscribed 29.76 times on October 3, 2023 7:02:00 PM. The public issue subscribed 16.06 times in the retail category, 20.83 times in the QIB category, and 73.64 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 20.83 |
| NII | 73.64 |
| bNII (bids above ₹10L) | 78.64 |
| sNII (bids below ₹10L) | 63.64 |
| Retail | 16.06 |
| Total | 29.76 |
Total Application : 676,145 (18.63 times)
| Listing Date | October 6, 2023 |
| BSE Script Code | 543998 |
| NSE Symbol | VALIANTLAB |
| ISIN | INE0JWS01017 |
| Final Issue Price | ₹140 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹140.00 |
| ₹161.00 |
| ₹161.00 |
| ₹169.05 |
| ₹169.05 |
| NSE |
|---|
| ₹140.00 |
| ₹162.15 |
| ₹162.10 |
| ₹170.25 |
| ₹170.25 |
Valiant Laboratories Limited
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Valiant Laboratories IPO is a main-board IPO of 10,890,000 equity shares of the face value of ₹10 aggregating up to ₹152.46 Crores. The issue is priced at ₹133 to ₹140 per share. The minimum order quantity is 105 Shares.
The IPO opens on September 27, 2023, and closes on October 3, 2023.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Valiant Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Valiant Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Valiant Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Valiant Laboratories IPO opens on September 27, 2023 and closes on October 3, 2023.
Valiant Laboratories IPO lot size is 105 Shares, and the minimum amount required is ₹14,700.
You can apply in Valiant Laboratories IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Valiant Laboratories IPO will be done on Thursday, October 5, 2023, and the allotted shares will be credited to your demat account by Friday, October 6, 2023. Check the Valiant Laboratories IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (1500+ Posts, 600+ Likes)
Top Contributor (300+ Posts, 100+ Likes)
IPO Mentor (600+ Posts, 300+ Likes)
